ABSTRACT
Non-governmental organizations (NGOs) have long been concerned about developments in genetic engineering and biotechnology and their potential adverse impacts. The biotechnology industry has not lived up to its claims or been proactive in addressing risk issues involving consumers and the environment. The range of expertise among NGO delegates – including experts in international law, regulatory affairs, genetic engineering, ecology and development issues – covered all areas of the negotiations. NGOs interacted with biotechnology industry representatives as well as with government delegates. The Convention on Biological Diversity Secretariat organized a meeting between NGOs and industry during BSWG-5, to exchange views on liability and redress. After the successful conclusion of the Cartagena Protocol, the main issues are its implementation, including capacity-building, and the agreement of a regime on liability and redress. Generally, the interactions between NGOs and industry were easier with European representatives, who were more open to constructive dialogue than some of their United State counterparts.
